Clinical Care Options Hepatitis - Normal ALT in Patients With Chronic HBV: Implications for Patient Management

Interactive Virtual Presentation

Clinical Utility of ALT in Diagnosis and Management of Chronic Hepatitis B

Program Director: Yun-Fan Liaw, MD

Faculty:

W. Ray Kim, MD

CREDIT INFORMATION

Release Date: March 16, 2009

Expiration Date: March 15, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.8 Nursing contact hours

Status: The activity is not currently available for credit.

W. Ray Kim, MD, discusses the importance of ALT in hepatitis B and outlines management approaches for patients with normal ALT levels.

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the role of ALT as a marker of liver injury in hepatitis B
Recount data describing the relationship between ALT levels and patient outcomes in hepatitis B
Review guidelines for monitoring ALT in HBeAg-positive and HBeAg-negative patients
Describe management strategies for HBV-infected patients with normal ALT levels

Slideset: Clinical Utility of ALT in Diagnosis and Management of Chronic Hepatitis B

W. Ray Kim, MD, discusses the importance of ALT in hepatitis B and outlines management approaches for patients with normal ALT levels.

Format: Microsoft PowerPoint (.ppt) | File size: 1.57 MB | Date posted: 3/16/2009

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

CCO Treatment Updates

Normal ALT in Patients With Chronic HBV: Implications for Patient Management